Comparison of Real-time and Shear Wave Elastography

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Recruiting
CT.gov ID
NCT03487471
Collaborator
(none)
98
1
2
45
2.2

Study Details

Study Description

Brief Summary

Tissue elasticity is being increasingly used as diagnostic parameter, since at the macroscopic level benign breast lesions tend to be stiffer than normal breast tissue but softer than breast cancers. Ultrasound elastography allows to probe the elasticity of breast lesions in clinics. Real time elastography (RTE) and shear wave elastography (SWE) are the two most widely used elastography modalities.

Assessment of breast lesions by either RTE or SWE improve the diagnostic performance of standard B-mode ultrasound (US) and have the potential to assist the decision about whether to perform a breast biopsy or not.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Real-time elastography
  • Diagnostic Test: Shear wave elastography
N/A

Detailed Description

Tissue elasticity is being increasingly used as diagnostic parameter, since at the macroscopic level benign breast lesions tend to be stiffer than normal breast tissue but softer than breast cancers. Ultrasound elastography allows to probe the elasticity of breast lesions in clinics. Real time elastography (RTE) and shear wave elastography (SWE) are the two most widely used elastography modalities.

Assessment of breast lesions by either RTE or SWE improve the diagnostic performance of standard B-mode ultrasound (US) and have the potential to assist the decision about whether to perform a breast biopsy or not. However, employing RTE and SWE using the same equipment to directly compare elasticity measurements of a breast lesion has not been done. Investigators propose to prospectively investigate inter-observer agreement of each modality.

The study will investigate and compare the accuracy and reproducibility of SWE and RTE in the characterization of breast lesions. Furthermore, we plan to establish learning curves for RTE and SWE.

In this project, investigators will compare RTE and SWE concerning their potential to discriminate benign breast lesions from breast cancer. Investigators aim is to identify which modality will allow clinicians the best possible patient care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
98 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparison of Accuracy and Reproducibility of Breast Lesion Characterization Between Real Time Elastography and Shear Wave Elastography
Actual Study Start Date :
Mar 1, 2018
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Real-time elastography

98 patients with breast lesion will a receive breast ultrasound (real time elastography)

Diagnostic Test: Real-time elastography
Breast ultrasound with real-time elastography

Active Comparator: Shear Wave

98 patients with breast lesion will a receive breast ultrasound (shear wave elastography)

Diagnostic Test: Shear wave elastography
Breast ultrasound with shear wave elastography

Outcome Measures

Primary Outcome Measures

  1. assessment of dignity of breast lesion by use of real-time elastography [at baseline]

    variability in breast lesion diagnostics by use of real-time elastography versus shear wave elastography

  2. assessment of dignity of breast lesion by use of shear wave elastography [at baseline]

    variability in breast lesion diagnostics by use of real-time elastography versus shear wave elastography

Secondary Outcome Measures

  1. Examinators learning curve [baseline until year 1]

    Establish learning curves for real-time elastography and shear wave elastography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female patients at least 18 years of age with a known breast lesion

  • Signed informed consent

Exclusion Criteria:
  • Male

  • Younger than 18 years of age

  • Pregnant or lactating women

Contacts and Locations

Locations

Site City State Country Postal Code
1 St Claraspital Basel Switzerland 4016

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Rosanna Zanetti, St Claraspital Basel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT03487471
Other Study ID Numbers:
  • Elasto Trial
First Posted:
Apr 4, 2018
Last Update Posted:
Oct 5, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2021